These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
93 related items for PubMed ID: 22685011
1. Hepatocarcinogenesis in non-cirrhotic liver is associated with a reduced number of clonal hepatocellular patches in non-tumorous liver parenchyma. Adam AC, Faudou V, Paschen SA, Adam OM, Kahl P, Drebber U, Fischer HP, Büttner R. J Pathol; 2012 Nov; 228(3):333-40. PubMed ID: 22685011 [Abstract] [Full Text] [Related]
2. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma. de Almeida TM, Leitão RC, Andrade JD, Beçak W, Carrilho FJ, Sonohara S. Cancer Genet Cytogenet; 2004 Apr 01; 150(1):16-21. PubMed ID: 15041218 [Abstract] [Full Text] [Related]
3. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver. Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM. Mod Pathol; 2003 Jan 01; 16(1):14-21. PubMed ID: 12527708 [Abstract] [Full Text] [Related]
4. The Sialyl Lewis X expression in hepatocarcinogenesis: potential predictor for the emergence of hepatocellular carcinoma. Fujiwara Y, Shimada M, Takenaka K, Kajiyama K, Shirabe K, Sugimachi K. Hepatogastroenterology; 2002 Jan 01; 49(43):213-7. PubMed ID: 11941958 [Abstract] [Full Text] [Related]
5. [Sequential cellular and molecular changes during hepatocarcinogenesis]. Bannasch P. Verh Dtsch Ges Pathol; 1995 Jan 01; 79():72-83. PubMed ID: 8600697 [Abstract] [Full Text] [Related]
6. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Hepatology; 1995 Mar 01; 21(3):760-6. PubMed ID: 7875675 [Abstract] [Full Text] [Related]
7. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study. Clemente C, Elba S, Buongiorno G, Guerra V, D'Attoma B, Orlando A, Russo F. Liver Int; 2007 Aug 01; 27(6):791-7. PubMed ID: 17617122 [Abstract] [Full Text] [Related]
8. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. Yeh MM, Larson AM, Campbell JS, Fausto N, Rulyak SJ, Swanson PE. Am J Surg Pathol; 2007 May 01; 31(5):681-9. PubMed ID: 17460450 [Abstract] [Full Text] [Related]
9. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver. Mun KS, Cheah PL, Baharudin NB, Looi LM. Malays J Pathol; 2006 Dec 01; 28(2):73-7. PubMed ID: 18376794 [Abstract] [Full Text] [Related]
10. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis. Wang LH, Huang W, Lai MD, Su IJ. Carcinogenesis; 2012 Feb 01; 33(2):466-72. PubMed ID: 22159224 [Abstract] [Full Text] [Related]
11. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S. J Viral Hepat; 2005 Nov 01; 12(6):635-41. PubMed ID: 16255765 [Abstract] [Full Text] [Related]
13. In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers. Hellerbrand C, Bataille F, Schlegel J, Hartmann A, Mühlbauer M, Schölmerich J, Büttner R, Hofstädter F, Bosserhoff AK. Liver Int; 2005 Apr 01; 25(2):357-66. PubMed ID: 15780062 [Abstract] [Full Text] [Related]
14. Morphological changes of early human hepatocarcinogenesis. Hytiroglou P. Semin Liver Dis; 2004 Feb 01; 24(1):65-75. PubMed ID: 15085487 [Abstract] [Full Text] [Related]
15. Bone marrow cells: the source of hepatocellular carcinoma? Wu XZ, Yu XH. Med Hypotheses; 2007 Feb 01; 69(1):36-42. PubMed ID: 17300877 [Abstract] [Full Text] [Related]
16. Hepatocellular carcinoma in a non-cirrhotic liver. Two case reports and literature review. Leone N, Volpes R, Carrera M, Pellicano R, De Paolis P, Fiorentino M, Fronda GR, Rizzetto M. Panminerva Med; 2000 Jun 01; 42(2):151-4. PubMed ID: 10965777 [Abstract] [Full Text] [Related]
17. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver. van Hengel J, D'Hooge P, Hooghe B, Wu X, Libbrecht L, De Vos R, Quondamatteo F, Klempt M, Brakebusch C, van Roy F. Gastroenterology; 2008 Mar 01; 134(3):781-92. PubMed ID: 18325391 [Abstract] [Full Text] [Related]
18. Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesis. Wu W, Yao DF, Qiu LW, Sai WL, Shen JJ, Yu HB, Wu XH, Li YM, Wang YL, Gu WJ. Hepatobiliary Pancreat Dis Int; 2009 Oct 01; 8(5):504-9. PubMed ID: 19822494 [Abstract] [Full Text] [Related]
19. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias. Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H. J Pathol; 2000 Oct 01; 192(2):207-15. PubMed ID: 11004697 [Abstract] [Full Text] [Related]
20. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Salomao M, Yu WM, Brown RS, Emond JC, Lefkowitch JH. Am J Surg Pathol; 2010 Nov 01; 34(11):1630-6. PubMed ID: 20975341 [Abstract] [Full Text] [Related] Page: [Next] [New Search]